Skip to main content
 

Therapeutic Opportunities in Glycoscience

Wednesday, October 21, 2020 - 3:00pm to 4:00pm

Speaker

Carolyn R. Bertozzi, Ph.D.
Baker Family Director, Stanford ChEM-H
Anne T. and Robert M. Bass Professor of Chemistry
Howard Hughes Medical Institute
Stanford University

Summary

Cell surface glycans constitute a rich biomolecular dataset that drives both normal and pathological processes. Their “readers” are glycan-binding receptors that can engage in cell-cell interactions and cell signaling. Our research focuses on mechanistic studies of glycan/receptor biology and applications of this knowledge to new therapeutic strategies. Our recent efforts center on pathogenic glycans in the tumor microenvironment and new therapeutic modalities based on the concept of targeted degradation.


The page was last updated on Thursday, October 15, 2020 - 5:17pm